HPβCD’s Promise in Treating Ischemic Stroke
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. 2-hydroxypropyl-β-cyclodextrin (HPβCD), a
Tag: stroke
HPBCD accesses acute and subacute infarcts in a mouse model of ischemic stroke
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. Researchers in Arizona
Oral Xenon/alpha-Cyclodextrin Provides Neuroprotection for Ischemic Stroke
Ischemic stroke is one of the main causes of long-term morbidity/mortality and early treatment of stroke is key issue. Xenon
Repeated administration of 2-hydroxypropyl-β-cyclodextrin (HPβCD) attenuates the chronic inflammatory response to experimental stroke
Globally, more than 67 million people are living with the effects of ischemic stroke. Importantly, many stroke survivors develop a